Skip to main content



) -- Shares of

Celldex Therapeutics



) were gapping down Friday morning with an open price 11% lower than Thursday's closing price. The stock closed at $4.36 Thursday and opened today's trading at $3.88.

The average volume for Celldex has been 308,700 shares per day over the past 30 days. Celldex has a market cap of $177 million and is part of the

health care

sector and


industry. Shares are up 67.7% year to date as of the close of trading on Thursday.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in the development, manufacture, and commercialization of novel therapeutics for human health care. The company offers Rotarix for the treatment of rotavirus infection.

Scroll to Continue

TheStreet Recommends

TheStreet Ratings rates Celldex as a


. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and feeble growth in its earnings per share. You can view the full

Celldex Ratings Report


Get more investment ideas from our

investment research center


Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options